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Abstract
The mature form of the envelope (Env) glycoprotein of lentiviruses is a heterodimer composed of the surface (SU) and transmembrane (TM)
subunits. Feline immunodeficiency virus (FIV) possesses a TM glycoprotein with a cytoplasmic tail of approximately 53 amino acids which is
unusually short compared with that of the other lentiviral glycoproteins (more than 100 residues). To investigate the relevance of the FIV TM
cytoplasmic domain to Env-mediated viral functions, we characterized the biological properties of a series of Env glycoproteins progressively
shortened from the carboxyl terminus. All the mutant Env proteins were efficiently expressed in feline cells and processed into the SU and TM
subunits. Deletion of 5 or 11 amino acids from the TM C-terminus did not significantly affect Env surface expression, fusogenic activity or Env
incorporation into virions, whereas removal of 17 or 23 residues impaired Env-mediated cell-to-cell fusion. Further truncation of the FIV TM by
29 residues resulted in an Env glycoprotein that was poorly expressed at the cell surface, exhibited only 20% of the wild-type Env fusogenic
capacity and was inefficiently incorporated into virions. Remarkably, deletion of the TM C-terminal 35 or 41 amino acids restored or even
enhanced Env biological functions. Indeed, these mutant Env glycoproteins bearing cytoplasmic domains of 18 or 12 amino acids were found to
be significantly more fusogenic than the wild-type Env and were efficiently incorporated into virions. Interestingly, truncation of the TM
cytoplasmic domain to only 6 amino acids did not affect Env incorporation into virions but abrogated Env fusogenicity. Finally, removal of the
entire TM cytoplasmic tail or deletion of as many as 6 amino acids into the membrane-spanning domain led to a complete loss of Env functions.
Our results demonstrate that despite its relatively short length, the FIV TM cytoplasmic domain plays an important role in modulating Env-
mediated viral functions.
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Feline immunodeficiency virus (FIV) is a lentivirus that
induces in cats a progressive disease similar to human AIDS
caused by human immunodeficiency virus (HIV) (Pedersen et
al., 1987). FIV is therefore intensively studied not only because
it constitutes an important health problem for domestic cats but
also as a useful model for HIV-1 infections in humans. FIV
infects a broad range of cell types such as CD4+ and CD8+ T⁎ Corresponding author. Fax: +54 11 4963 9278.
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doi:10.1016/j.virol.2007.05.019lymphocytes, B lymphocytes and macrophages (Brown et al.,
1991; Brunner and Pedersen, 1989; Dean et al., 1999; Dow et al.,
1999; English et al., 1993). Entry of FIV into their target cells is
initiated by the specific interaction of the viral envelope
glycoprotein (Env) with cellular receptors. In contrast to HIV-
1, FIV does not utilize the CD4 molecule as primary receptor
(Hosie et al., 1993). However, the FIV Env protein binds to the
chemokine receptor CXCR4 (Poeschla and Looney, 1998)
which is used as coreceptor by T-tropic HIV-1 strains
(Richardson et al., 1999; Willett et al., 1997). Furthermore,
productive infection of feline CD4+ T cells requires, in addition
to virus interaction with CXCR4, Env attachment to the recently
identified cell surface receptor CD134 (de Parseval et al., 2004;
406 C.C.P. Celma et al. / Virology 366 (2007) 405–414Shimojima et al., 2004). Thus, bymediating virus entry, FIV Env
plays a key role in determining viral tropism and pathogenesis.
FIV Env, like that of other lentiviruses, is synthesized as a
heavily glycosylated precursor which is cleaved by cellular
proteases into the surface (SU) and transmembrane (TM)
subunits which remain associated by non-covalent interactions.
Translation of the FIV env open reading frame yields a protein
product of approximately 150 kDa which is processed into a
130-kDa species by removal of an unusually long N-terminal
signal peptide (Verschoor et al., 1993). The 130-kDa Env
molecule is then further processed into two polypeptides of
95 kDa and 36 kDa which correspond to the SU and TM
glycoproteins, respectively (Verschoor et al., 1993). Evidence
has been presented indicating that the SU and TM subunits of
FIV Env perform similar functions to those of their HIV-1
counterparts. Indeed, the FIV SU appears to mediate binding to
the cell surface receptors (de Parseval and Elder, 2001),
whereas the FIV TM mediates fusion of the viral membrane
with that of the target cell (Garg et al., 2004; Giannecchini
et al., 2004).
The TM subunit of lentiviral Env glycoproteins shares a
conserved structural organization: an ectodomain containing a
hydrophobic fusion peptide, a single membrane-spanning
domain and a C-terminal cytoplasmic region (Hunter, 1997).
A characteristic feature of most lentiviral TM proteins is the
presence of a cytoplasmic tail of 100–200 amino acids, whose
length contrasts with that (30–40 amino acids) of other
retroviral Env proteins (Hunter and Swanstrom, 1990). The
biological function of the long cytoplasmic domain of lentiviral
Env proteins has been the subject of several studies essentially
focused on HIV-1 and simian immunodeficiency virus (SIV). In
this regard, mutations in the Env cytoplasmic tail of these
viruses have been shown to affect viral functions, such as
regulation of Env expression at the cell surface (Berlioz-Torrent
et al., 1999; LaBranche et al., 1995), syncytium formation (Earl
et al., 1991; Gabuzda et al., 1992; Ritter et al., 1993) and virus
infectivity (Chakrabarti et al., 1989; Dubay et al., 1992).
Moreover, we and others have demonstrated that domains
within the C-terminal third of the HIV-1 and SIV Env
cytoplasmic tail are responsible for Env glycoprotein incorpora-
tion into virions by establishing specific interactions with the
matrix (MA) domain of the viral Gag polyprotein (Celma et al.,
2001; Freed and Martin, 1995, 1996; González et al., 1996;
Kalia et al., 2003; Mammano et al., 1995; Piller et al., 2000;
Manrique et al., 2001, 2003; Murakami and Freed, 2000; Yu et
al., 1993). Taken together, these studies highlight the important
role played by the TM cytoplasmic domain in Env-mediated
viral functions. However, compared with the amount of
information available for the cytoplasmic regions of HIV-1
and SIV Env proteins, little is known about the function of the
equivalent region in other lentiviruses. In particular, the analysis
of the FIV TM cytoplasmic region seems relevant since it is
unusually short (about 50 amino acids) when compared not only
with that of primate lentiviruses (150 and 164 residues for HIV-
1 and SIV, respectively) but also with that of lentiviruses of
ungulate animals, such as caprine arthritis and encephalitis virus
(129 residues), equine infectious anemia virus (200 residues)and visna virus (126 residues) (Rice et al., 1990; Saltarelli et al.,
1990; Sonigo et al., 1985).
Given the importance of the Env glycoprotein in the
lentiviral life cycle, in the present report we investigated the
role that the FIV TM cytoplasmic domain plays in modulating
Env structure and function. We studied how variations in the
length of the Env cytoplasmic region affect the synthesis,
processing, cell surface expression, incorporation into virions
and fusogenic capacity of the FIV Env glycoprotein.
Results
Construction of FIV Env mutants carrying premature stop
codon mutations in the TM cytoplasmic region
Based on computer-assisted programs that predict protein
secondary structure and hydrophobicity, it has been proposed
that the membrane-spanning domain of the FIV TM protein
comprises Env residues 786–812 which would result in a TM
cytoplasmic domain of 53 amino acids (Verschoor et al.,
1993). However, the boundaries of the FIV Env membrane-
spanning domain and the length of the TM cytoplasmic region
need to be experimentally confirmed. To study the biological
functions of the FIV Env cytoplasmic domain, we performed a
mutagenesis analysis of the C-terminal 59 amino acids of Env.
We engineered into the env gene of the infectious molecular
clone FIV-14 of the Petaluma isolate a series of premature stop
codon mutations so as to progressively truncate the TM C-
terminus by 5, 11, 17, 23, 29, 35, 41, 47, 53 or 59 amino acids
(Fig. 1). Among these Env constructs, mutants TM198,
TM192 and TM186 were designed to help define the
cytoplasmic border of the Env membrane-spanning domain
(Fig. 1).
Synthesis and processing of the FIV Env glycoproteins bearing
truncated cytoplasmic domains
We first investigated whether the progressive truncation of
the FIV TM cytoplasmic region had any effect on Env synthesis
and processing. To this end, wild-type and Env mutant proviral
DNAs were transfected in parallel into Crandell feline kidney
(CrFK) cells and 48 h post-transfection both the cell lysates and
the clarified cell culture supernatants were analyzed by Western
blotting (Fig. 2). Immunoblotting of the cell lysates with an anti-
SU monoclonal antibody (MAb) revealed that all the mutant
FIV Env proteins were expressed as efficiently as wild-type
Env, as inferred from the detection of wild-type levels of the
mutant Env proteins (Fig. 2A). When the cell-associated viral
proteins were resolved on 7.5% polyacrylamide gels and probed
with an anti-TM polyclonal serum, it was observed that the
mutant Env precursor glycoproteins exhibited an increased
electrophoretic mobility with respect to the wild-type Env,
which is in agreement with the expected molecular weight
reduction resulting from the premature stop codon mutations
introduced into the env gene (Fig. 2A). Furthermore, all the
mutant Env proteins were found to be processed since the SU
glycoprotein was detected in both the cell lysates and cell
Fig. 1. Construction of the FIV Env truncation mutants. The wild-type (WT) FIV Env glycoprotein is depicted at the top showing the cleavage site between its SU and
TM subunits (arrow). The structural features of the TM glycoprotein are shown: ectodomain (black box), membrane-spanning domain (gray box) and cytoplasmic
region (open box). Amino acid numbering corresponds to the Env protein of the Petaluma FIV-14 isolate. The Env truncation mutants are named according to the
length of their TM subunits, whereas the numbers at the right of each construct refer to the length of the cytoplasmic domain resulting from the introduction of the stop
codon mutations in the env gene.
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and extracellular levels of the Env glycoproteins showed that
mutants TM240, TM234, TM228, TM222, and TM210 were
processed with an efficiency similar to or slightly lower than
that of wild-type Env, whereas the degree of mutant TM216
processing was less than 50% of the wild-type value (Fig. 2B).
By contrast, the Env mutants bearing a cytoplasmic domain of
12 or 6 amino acids were found to be processed more efficiently
than wild-type Env, exhibiting processing indices of 1.53
(mutant TM204) and 1.37 (mutant TM198) (Fig. 2B). Likewise,
removal of the entire TM cytoplasmic domain (mutant TM192)
as well as C-terminal truncation of the TM glycoprotein by as
many as 6 amino acids into the putative membrane-spanning
domain (mutant TM186) also led to enhanced Env processing
(Fig. 2B). In addition, mutations TM204 to TM186 reduced the
stability of the SU-TM association with respect to that of wild-
type Env. Indeed, these mutants exhibited association indices
ranging from 0.49 to 0.62 (Fig. 2B), together with enhanced
shedding of the SU glycoprotein (Fig. 2A). Of note, when the
cell lysates were probed with a polyclonal serum directed
against the TM ectodomain, we could not detect the bands
corresponding to the TM subunits of mutants TM192 and
TM186 (Fig. 2C). This suggests that either both mutant Env
precursors are not stably anchored in the plasma membrane or
that after Env processing, the TM subunits of these mutants are
rapidly degraded. However, the fact that neither the Env
precursors of mutants TM192 and TM186 nor their TM
subunits could be detected in the cell culture supernatants by
using the anti-TM serum (data not shown) favors the latter
possibility.
It should be mentioned that mutations TM240 and TM234
that introduce nucleotide changes into the Rev responsive
element (nucleotides 8785–8928 in the FIV genome; Phillips et
al., 1992) do not disrupt its function, since wild-type levels of
Gag (Fig. 2D) and Env proteins (Fig. 2A) were detected in cells
expressing these TM mutants.Cell surface expression of the FIV Env mutants
To examine whether progressive truncation of the FIV TM
cytoplasmic domain affected the transport of the Env proteins to
the plasma membrane, we performed cell surface biotinylation
of CrFK cells transfected in parallel with the wild-type or
mutant FIV proviral DNAs. In the case of the wild-type FIV
Env, surface biotinylation resulted mainly in the detection of the
Env precursor (Fig. 3). The difficulty in detecting the FIV SU
glycoprotein at the cell surface may be related to the low levels
of intracellular SU protein detected in transfected cells (Fig. 2A;
Pancino et al., 1995; Verschoor et al., 1993). Comparison of the
cell surface levels of the wild-type FIV Env precursor with
those of the mutant Env proteins revealed that all mutant Env
glycoproteins were transported to the plasma membrane, albeit
with different efficiencies (Fig. 3A). Mutants TM240, TM234,
TM228, TM210 and TM204 were present at the cell surface at
levels comparable to those of wild-type Env (Fig. 3B). A
moderate defect in cellular transport was caused by mutations
TM222, TM198 and TM192. Indeed, these mutants exhibited
levels of surface-associated Env precursor ranging from 51% to
60% of those of wild-type Env (Fig. 3B). The most drastic effect
on Env surface expression was observed for mutants TM216
and TM186 whose levels at the cell membrane were found to be
reduced by approximately 72% and 84%, respectively, when
compared to those of wild-type Env.
Fusogenic capacity of the FIV TM mutants
Following the interaction of the SU subunit of the FIV Env
with the receptor–coreceptor complex present at the surface of
the target cells, the TM glycoprotein mediates fusion of the viral
and cellular membranes, thereby allowing virus entry. Thus,
Env function can be assessed by evaluating its ability to mediate
cell–cell fusion. To analyze the fusogenic capacity of the FIV
Petaluma Env protein, we developed a sensitive and consistent
Fig. 2. Synthesis and processing of the FIV Env truncation mutants. CrFK cells were transfected with the wild-type (WT) or TM mutant FIV proviral clones. At 48 h
post-transfection, viral proteins from cell lysates (CELLS) and culture supernatants (SUPERNATANTS) were transferred to nitrocellulose membranes and subjected to
Western blotting using different antibodies. (A) Immunoblotting of cell lysates (10% polyacrylamide gel) and culture supernatants (7.5% polyacrylamide gel) with a
MAb directed to the FIV SU glycoprotein (anti-SU). Cell lysates (resolved on 7.5% polyacrylamide gel) were also probed with a polyclonal serum against the FIV TM
protein (anti-TM). The mobilities of the FIV Env precursor (Pre) and the SU subunit (SU) are shown, as are those of the molecular weight standards. (B) The amounts
of Env precursor and SU proteins for wild-type and TM mutants in the cell lysates and culture supernatants were quantitated and the resulting values were used to
calculate the processing and association indices. Processing index: ([total SU]mutant× [Env precursor]wild-type) / ([Env precursor]mutant× [total SU]wild-type), where total
SU corresponds to the amounts of SU detected in both cell lysates and supernatants. Association index: ([intracellular SU]mutant× [total SU]wild-type) / ([total
SU]mutant× [intracellular SU]wild-type), where intracellular SU denotes the SU levels detected in cell lysates. The data presented are the mean values and standard
deviations of three independent assays. (C) Immunoblotting of cell lysates using an anti-TM polyclonal serum. Proteins were resolved on a 11% polyacrylamide gel.
The mobilities of the wild-type and truncated TM proteins are shown. (D) Probing of cell lysates with a MAb specific for the FIV capsid (CA) protein. The mobilities
of the Gag and CA proteins are indicated.
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and human CXCR4 cells (see Materials and methods). 293T
cells were cotransfected with the pcDNA-ΔU3FIV proviral
DNA, an FIV DNA construct that allows viral proteins to be
efficiently expressed in human cells, and a plasmid encoding the
HIV-1 Tat protein. Forty-eight hours after transfection, the cells
were dissociated and added to MAGI-CXCR4 indicator cells
(HeLa-CD4-LTR-β-galactosidase; Kimpton and Emerman,
1992). Coculture was continued for 48 h after which cells
were stained for β-galactosidase activity and scored for syncytia
formation. The choice of the MAGI cell line as the target
indicator cells in this assay was based on the fact that cell fusion
mediated by the Petaluma Env protein is only CXCR4-dependent and does not require the CD134 cellular receptor
(Shimojima et al., 2004). Under these experimental conditions,
293T cells expressing wild-type FIV Env yielded 1077±178
blue syncytia per well (average of four assays±SD). By
contrast, mixing of MAGI-CXCR4 cells with 293T cells
expressing HIV-1 Tat alone did not yield any blue cells.
When the fusogenic capacity of the FIV TM mutants was
evaluated, we found that removal of the C-terminal 5 or 11
amino acids from the TM cytoplasmic domain (mutations
TM240 and TM234) did not affect Env-mediated cell-to-cell
fusion (Table 1). Further truncation of the FIV Env C-terminus
by 17, 23 or 29 amino acids (mutations TM228, TM222, and
TM216) increasingly inhibited Env fusogenic capacity. Indeed,
Fig. 3. Cell surface expression of the FIV Env truncation mutants. CrFK cells
were transfected with the wild-type (WT) or TMmutant FIV proviral DNAs and
biotinylated as described in Materials and methods. (A) Env proteins were
immunoprecipitated from cell lysates, separated by SDS-polyacrylamide gel
electrophoresis, and transferred to nitrocellulose membranes. Proteins on the cell
surface were visualized by using streptavidin–horseradish peroxidase conjugate
coupled with enhanced chemiluminescence. The mobility of the Env precursor
protein is shown. (B) Levels of surface-associated Env precursor for each TM
mutant relative to those of wild-type Env.
409C.C.P. Celma et al. / Virology 366 (2007) 405–414mutant TM216 mediated cell-to-cell fusion with an efficiency
representing only 20% of the wild-type value (Table 1).
Interestingly, FIV Env proteins bearing a cytoplasmic domain
of 18 or 12 amino acids (mutantsTM210 and TM204) were
found to be significantly more fusogenic (approximately 1.5-
fold) than the wild-type Env. A drastic change in the level of
fusion was observed when the length of the TM cytoplasmic
domain was shortened from 12 amino acids (mutant TM204) toTable 1
Cell-to-cell fusion mediated by FIV Env mutant glycoproteins a












a 293T cells expressing the wild-type or the mutant FIV Env glycoproteins
together with HIV-1 Tat protein were dissociated and equivalent numbers of
cells were added at 1:5 ratio to 4×104 MAGI-CXCR4 cells. Coculture was
continued for 48 h, after which cells were stained for β-galactosidase and scored
for syncytia formation. A fraction of the transfected 293T cells was subjected to
immunoblotting to monitor Env expression.
b Data presented were obtained from three independent experiments, and each
assay was performed in triplicate. Blue foci were counted in at least 20 fields,
and the mean number of syncytia per field was referred to that obtained for wild-
type Env; ±standard deviations.
c No blue syncytia were detected.6 residues (mutant TM198). The latter mutation resulted in a
reduction of fusion by 94% with respect to the wild-type value
(Table 1). Moreover, removal of the C-terminal 53 amino acids
of the FIV Env glycoprotein (mutant TM192) as well as further
truncation of the TM protein by 6 residues into the membrane-
spanning domain (mutant TM186) abolished Env fusogenicity
(Table 1). Our results indicate that progressive truncation of the
FIV TM cytoplasmic domain severely affects Env fusogenic
capacity.
Effect of progressive truncation of the FIV TM cytoplasmic
domain on Env incorporation into virions
We next investigated the ability of the mutant Env
glycoproteins to be incorporated into virions. To this end,
CrFK cells were transfected with either the wild-type or the
mutant proviral DNAs, and 48 h post-transfection virions were
purified by ultracentrifugation from the clarified cell culture
supernatants. Virion lysates were analyzed for the presence of
viral proteins by Western blotting. The process of Env
incorporation into virions was first examined by analyzing the
levels of virion-associated SU protein (Fig. 4A). Most of the
mutant Env glycoproteins (mutants TM240 to TM222 and
mutants TM210 to TM198) were incorporated into virions at
levels similar to those of wild-type Env. By contrast, the SU
glycoprotein of Env mutants TM216, TM192 and TM186 was
not detected on virions, indicating that these mutations cause a
drastic defect in Env incorporation.
Further analysis of virion samples with the anti-TM serum
(Fig. 4B) paralleled the results obtained with the anti-SU MAb.
Indeed, virion-associated TM protein was readily detected for
mutants TM240 to TM222 and for mutants TM210 to TM198,Fig. 4. Incorporation of truncated Env glycoproteins into virions. CrFK cells
were transfected with the wild-type (WT) or TMmutant proviral DNAs. At 48 h
post-transfection, virions were purified and viral proteins were analyzed by
Western blotting using antibodies specific for the FIV SU, TM or CA proteins.
The mobilities of the SU, TM, Gag and CA proteins are shown. The positions of
the molecular weight standards are indicated on the left.
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transfected with the mutant TM192 and TM186 proviral
constructs. In the case of mutant TM216, the TM glycoprotein
could be detected on virions, albeit at levels representing
approximately 10% of the wild-type value. Of note, the mutant
TM204 Env glycoprotein was incorporated into virions more
efficiently than the wild-type Env, exhibiting levels of virion-
associated SU and TM proteins (relative to those of capsid
protein) corresponding to 149.7±5.2% and 139.5±10.7%,
respectively, of those found in wild-type virions. This indicates
that truncation of the TM cytoplasmic domain to 12 amino acids
enhances FIV Env incorporation into virions.
Discussion
FIV is unique among lentiviruses since it exhibits an Env
glycoprotein with a putative cytoplasmic domain of 53 amino
acids which is significantly shorter than that of the rest of the
lentiviral glycoproteins that range in size from 100 to 200
residues. Based on this particular feature of the FIV Env
glycoprotein, in this paper we addressed whether variations in
the length of the TM cytoplasmic tail had any effect on Env-
mediated viral functions. We inserted by site-directed mutagen-
esis a series of stop codon mutations into the coding region for
the C-terminal domain of the FIV TM in order to generate Env
mutants bearing progressively truncated cytoplasmic tails.
All the mutant Env glycoproteins were expressed in feline
cells at levels comparable to those of the wild-type Env and
were normally processed into the SU and TM subunits.
However, increased shedding of the SU glycoprotein into the
cell culture supernatants was observed for those mutants
bearing cytoplasmic tails of 12 or 6 amino acids (mutants
TM204 and TM198), indicating that these mutations reduce the
stability of the SU-TM association. A similar phenotype was
exhibited by mutant TM192 in which the entire Env
cytoplasmic tail was removed and by mutant TM186 which
bears a large C-terminal deletion extending by 6 amino acids
into the membrane-spanning domain. Moreover, we found that
in the case of mutants TM192 and TM186 the TM subunit of
Env could not be detected in transfected feline cells by Western
blotting. The fact that the SU subunits of these Env mutants
were readily detected in both cell lysates and cell culture
supernatants indicates that the Env precursors of mutants
TM192 and TM186 are transported through the secretory
pathway and efficiently processed but upon Env cleavage, the
SU-TM complex becomes unstable which in turn leads to the
release of the SU subunit and degradation of the TM
glycoprotein. This also explains the complete loss of membrane
fusion activity and lack of Env incorporation into virions
observed for mutants TM192 and TM186 (see below).
The presence of biologically functional FIV Env complexes
on the cell surface was investigated by fusion assays using
human cells expressing the mutant Env glycoproteins and
MAGI-CXCR4 indicator cells, an approach that provided a
highly quantitative measure of the Env syncytium-forming
ability. Removal of the C-terminal 5 or 11 amino acids from the
FIV TM did not significantly affect Env fusogenicity. Bycontrast, further truncation of the TM cytoplasmic tail by 17, 23
or 29 residues impaired Env-mediated cell-to-cell fusion by
47%, 63% and 80%, respectively, compared to the wild-type
Env fusogenic capacity. Remarkably, when 35 or 41 amino
acids were deleted from the TM C-terminus (mutants TM210
and TM204), the resulting Env glycoproteins were more
fusogenic than the wild-type Env. Noteworthy, these mutant
Env glycoproteins, which bear cytoplasmic tails of 18 or 12
amino acids, lack the GYTVL motif (TM residues 211–214)
which is analogous to the tyrosine-containing endocytosis motif
GYXXÖ present in the cytoplasmic domains of HIV-1 and SIV
Env proteins (Hosie et al., 2005). Although our biotinylation
experiments did not allow us to unequivocally detect the
surface-associated SU glycoprotein of these Env mutants, it is
tempting to speculate that the enhanced fusogenic capacity of
mutants TM210 and TM204 with respect to wild-type Env may
be related to increased levels of biologically active SU
glycoprotein at the cell surface due to a reduced rate of mutant
protein endocytosis. Alternatively, shortening the FIV TM
cytoplasmic tail to 18 or 12 residues may facilitate Env mobility
on the membrane thereby promoting Env clustering during
membrane fusion. Another possibility is that removal of 35 or
41 amino acids from the TM C-terminus may cause structural
changes in the TM ectodomain, favoring the necessary folding
transitions into the fusion-active state which would result in
increased fusion efficiency or kinetics. In support of the notion
that the TM cytoplasmic domain plays an important role in
modulating Env structure, it has been shown that deletions at the
TM C-terminus affect the fusion kinetics of HIV-1 Env (Wyss et
al., 2005), the exposure of HIV-1 SU epitopes (Edwards et al.,
2002) and the strength of the SU-TM association on SIV virions
(Affranchino and González, 2006).
It is interesting to compare the phenotype of mutants TM210
and TM204, which were found to be more fusogenic than wild-
type Env, with that of mutant TM198. The latter Env mutant,
whose cytoplasmic domain is only 6 amino acids shorter than
that of mutant TM204, is highly inefficient at mediating cell-to-
cell fusion. Indeed, mutant TM198 exhibits only 6% of the
wild-type Env syncytium-forming ability. Similarly, removal of
the entire cytoplasmic tail (mutant TM192) or deletion of as
many as 6 amino acids into the membrane-spanning domain
(mutant TM186) abrogates Env fusogenicity. Taken together,
our results indicate that the FIV TM cytoplasmic tail tolerates
only a moderate reduction in its length without losing its full
fusogenic ability. However, truncation of the TM cytoplasmic
region to 18 or 12 amino acids results in Env glycoproteins with
more fusogenic activity than the wild-type Env. In this regard, it
has been well documented that in the primate lentiviruses HIV-1
and SIV, certain properties of the Env glycoproteins such as
membrane fusion and cell tropism can also be augmented by
truncating their cytoplasmic tails to 18 amino acids (Johnston et
al., 1993; Spies and Compans, 1994; Zingler and Littman,
1993). It is therefore interesting to conclude that, irrespective of
the original size of the TM cytoplasmic tail, a length of 18
amino acids for this region appears to be optimal for the
biological activities displayed by diverse lentiviral Env pro-
teins. However, there is a strong selection pressure to maintain
411C.C.P. Celma et al. / Virology 366 (2007) 405–414in vivo an Env glycoprotein with an intact cytoplasmic domain
(Kodama et al., 1989). This probably reflects, as we have
previously proposed for SIV Env (Manrique et al., 2001), the
presence at the Env C-terminus of molecular determinants
required for full virus pathogenicity or a viral replication strategy
that requires Env expression and function to be kept tightly
regulated.
A critical step in the late stages of the lentiviral life cycle is
the incorporation of the Env glycoprotein into virions. For HIV-
1 and SIV, we and others have demonstrated that this process is
mediated by specific interactions between the TM cytoplasmic
tail and the MA domain of Gag (Celma et al., 2001; Freed and
Martin, 1996; Manrique et al., 2003; Murakami and Freed,
2000; Wyma et al., 2000). The requirement in primate
lentiviruses of specific protein–protein interactions for Env
incorporation reflects the complexity of the mechanism by
which the Gag-made particles accommodate an Env glycopro-
tein with a long cytoplasmic tail. It was therefore interesting to
investigate whether in FIV the integrity of the relatively short
TM cytoplasmic region was also necessary for Env incorpora-
tion into particles. Our mutagenesis studies show that most of
the truncated FIV Env glycoproteins were efficiently packaged
into virions. The sole exceptions were Env mutants TM216,
TM192 and TM186. In the case of the defect in Env
incorporation observed for mutant TM216, it is probably
related to the inefficient expression of this mutant on the cell
surface as inferred from the results of the biotinylation
experiments, whereas for mutants TM192 and TM186, their
inability to be packaged into particles most likely reflects the
instability of the SU-TM complex after Env processing which
causes SU secretion and TM degradation. In marked contrast,
mutant TM204 was found to be incorporated into virions at
levels significantly higher than those of wild-type Env.
Therefore, abbreviation of the FIV TM cytoplasmic tail to 12
amino acids not only enhances Env fusogenicity but increases
Env incorporation levels as well. At least two explanations that
are not mutually exclusive may account for the increased ability
of mutant TM204 to be packaged into particles. Truncation of
the FIV TM cytoplasmic tail to 12 amino acids may: (i) increase
mutant Env density on the cell surface thereby augmenting the
number of Env molecules available for association with the
assembling particles; or (ii) favor the association of the TM
cytoplasmic region with Gag either by facilitating protein–
protein interactions or by relieving the process of Env
incorporation from the sterical constraints imposed by the size
of the intact TM cytoplasmic tail.
In summary, our results demonstrate that, despite the
relatively short size of the FIV TM cytoplasmic tail, small




293T, CrFK and MAGI-CXCR4 cells were grown in
Dulbecco's modified Eagle's medium supplemented with 10%fetal bovine serum (FBS, GIBCO). MAGI-CXCR4 cells were
additionally maintained in medium containing 0.2 mg/ml G418
(geneticin), 0.1 mg/ml hygromycin B and 1 μg/ml puromycin.
MAbs and antisera
Pooled sera from FIV-infected cats were kindly provided by
E. Hoover. MAbs used to detect FIV Gag and CA proteins
(PAK3-2C1) and FIV SU (SUFc1-30) were obtained from the
NIH Research and Reference Reagent Program. To detect the
FIV TM protein we used a mouse polyclonal antibody obtained
in our laboratory. A peptide derived from the FIV TM
ectodomain (amino acids 628–784 in the FIV Env) was
expressed in E. coli as a fusion protein with glutathione-S-
transferase and purified by affinity chromatography using
glutathione-Sepharose 4B (GE Life Sciences). Six-week old
female BALB/c mice were immunized intraperitoneally with
50 μg of the recombinant fusion protein emulsified in complete
Freund's adjuvant. Two booster injections were administered
intraperitoneally in incomplete Freund's adjuvant at intervals of
2 weeks. Blood was collected at the end of the immunization
regimen and the presence of anti-FIV TM antibodies was
assessed by Western blotting against the recombinant FIV TM-
derived peptide and cell lysates of CrFK cells transfected with
FIV proviral DNA.
Construction of FIV mutant proviruses
All FIV Env mutant proviruses were derived from the
infectious clone FIV-14 of the Petaluma isolate (Olmsted et al.,
1989). The TM cytoplasmic tail mutations were created by
asymmetric PCR-based site-directed mutagenesis as we have
previously described (Manrique et al., 2001, 2004) using the
Elongase enzyme high-fidelity PCR mix (Invitrogen) and
antisense oligonucleotides carrying stop codon mutations.
Mutagenesis was performed on a SpeI–NotI restriction
fragment which corresponds to nucleotides (nt) 8287–9474 of
the FIV genome. Each SpeI–NotI fragment carrying the
corresponding stop codon mutation was substituted for the
wild-type counterpart in the parental FIV construct. The
presence of the desired mutations was confirmed by DNA
sequencing. To express the wild-type and mutant FIV genomes
in human 293T cells, the U3 element of the 5′ long terminal
repeat (LTR) was removed and the resulting proviral constructs
were cloned under the control of the human immediate early
cytomegalovirus (CMV) promoter using a strategy similar to
that described by Poeschla and Looney (1998). Briefly, the wild-
type and Env mutant molecular clones of FIV-14 in plasmid
pSV-SPORT were digested with SalI–Tth111I to remove the
fragment encompassing the entire 5′LTR and the beginning of
the gag gene (nt 1–924). Then, a SalI–Tth111I-tailed PCR
fragment extending from the R-U5 region of the 5′LTR to the
gag gene (nt 216–924) was ligated into the SalI–Tth111I-
digested pSV-FIV-14 plasmids in order to generate the wild-type
and Env mutant pSV-ΔU3FIV-14 constructs. The ΔU3FIV
genomes were excised from the pSV-SPORT backbone by
digestion with SmaI–NotI and cloned into the pCDNA3.1 vector
412 C.C.P. Celma et al. / Virology 366 (2007) 405–414(Invitrogen), thereby placing the ΔU3FIV genomes immedi-
ately downstream of the pCDNA CMV promoter. To create a
construct expressing the HIV-1 tat and rev genes under the
control of the HIV-1 LTR, the env-minus pNL4-3 plasmid
(Celma et al., 2001) was digested with EcoRI–SpeI, blunt-ended
with the Klenow fragment of DNA polymerase I and religated.
Thus, the env-minus HIV-1 genome was deleted of nt 1442 to
5742 thereby eliminating the open reading frames of the gag and
pol genes.
Transfections
CrFK or 293T cells (grown in 60-mm-diameter dishes) were
transfected with 10 μg of the proviral DNAs by using
Lipofectamine 2000 (Invitrogen) and harvested 48 h post-
transfection.
Mutant glycoprotein expression
Wild-type or mutant Env proviral DNAs were transfected
into CrFK cells as described above. Transfected cells were
washed twice with ice-cold phosphate-buffered saline (PBS)
and lysed at 4 °C in lysis buffer (50 mM Tris–HCl [pH 8.0],
150 mM NaCl, 1% Nonidet P-40, 0.1% SDS, 0.5% sodium
deoxycholate, 1 mM phenylmethylsulfonyl fluoride [PMSF]
and 10 μg/ml aprotinin), whereas the culture supernatants from
the transfected cells were filtered through 0.45-μm-pore-size
syringe filters. Cell lysates and culture supernatants were
resolved by SDS-polyacrylamide gel electrophoresis (SDS-
PAGE), blotted onto nitrocellulose membranes and analyzed by
Western blotting using the SUFc1-30 MAb to detect the FIV SU
or the mouse anti-FIV TM polyclonal serum obtained in our
laboratory. Horseradish peroxidase-conjugated anti-mouse
immunoglobulin (GE Life Sciences) was used as secondary
antibody. Western blots were developed with an enhanced
chemiluminescence and chemifluorescence assay (ECL Plus
Reagent, GE Life Sciences) and the resulting signal was
quantitated as previously described (Manrique et al., 2003).
Cell surface biotinylation
Biotinylation of surface proteins in transfected cells was
carried out essentially as we have previously described
(Affranchino and González, 2006; Celma et al., 2001). Briefly,
CrFK cells grown in 35-mm-diameter dishes were transfected
with 4 μg of the wild-type or each of the Env mutant proviral
DNAs. At 48 h post-transfection, cells were rinsed three times
in ice-cold PBS and were then incubated for 30 min with the
membrane-impermeable biotinylating reagent biotinamido-
caproate N-hydroxysuccinamide ester in 40 mM sodium
bicarbonate buffer (pH 8.6) (ECL Protein Biotinylation System;
GE Life Sciences) at 4 °C. The reaction was quenched by
washing the cell monolayer twice with ice-cold PBS and the
cells were then lysed in lysis buffer. The cell lysates were
immunoprecipitated with pooled sera of FIV-infected cats and
viral proteins were separated on SDS-7.5% polyacrylamide gels
and transferred to nitrocellulose membranes. Cell surfaceproteins were visualized by using streptavidin–horseradish
peroxidase conjugate and ECL. To analyze total Env expres-
sion, a blot containing a fraction of the immunocomplexes was
probed with the anti-SU MAb SUFc1-30.
Cell–cell fusion assays
To examine the ability of the mutant FIV Env glycoproteins
to mediate cell-to-cell fusion, 293T cells were transiently
transfected with the pCDNA-ΔU3 FIV proviral DNAs together
with the HIV-1 tat/rev expression construct. Forty-eight hours
post-transfection, the cells were dissociated and equivalent
numbers of cells were added, in triplicate, at a 1:2 or 1:5 ratio to
4×104 MAGI-CXCR4 target cells in 24-well plates. Coculture
was continued for 48 h, after which cells were stained for β-
galactosidase and scored for syncytium formation as described
previously (Affranchino and González, 2006). Syncytia were
counted by visual microscopy at 100X magnification. The total
number of syncytia (containing five or more nuclei) per field
was counted for at least 20 randomly selected fields, and the
data were reported as the mean number of blue foci per field.
Analysis of Env incorporation into virions
CrFK cells were transfected with the wild-type or Env mutant
proviral DNAs and 48 h post-transfection cells were washed
twice with ice-cold PBS and lysed at 4 °C in lysis buffer. Virions
were pelleted from the cell-free culture supernatants by ultra-
centrifugation (100,000×g, 90 min, 4 °C) through a 20% (wt/v)
sucrose cushion as we have previously described (Manrique
et al., 2004). Cell- and virion-associated proteins were resolved
by SDS-PAGE, blotted onto nitrocellulose membranes and
analyzed by Western blotting using the PAK3-2C1 MAb to
detect the FIV Gag and CA proteins, the SUFc1-30 MAb to
detect the FIV SU and themouse anti-TM polyclonal antibody to
detect the FIV TM.
Acknowledgments
This work was supported by the Agencia Nacional de
Promoción Científica y Tecnológica (ANPCyT, Argentina)
Grant 14035 to J.L.A. S.A.G. and J.L.A. are Career Investigators
of the National Research Council of Argentina (CONICET).
References
Affranchino, J.L., González, S.A., 2006. Mutations at the C-terminus of the
simian immunodeficiency virus envelope glycoprotein affect gp120–gp41
stability on virions. Virology 347, 217–225.
Berlioz-Torrent, C., Shacklett, B.L., Erdtmann, L., Delamarre, L., Bouchaert, I.,
Sonigo, P., Dokhélar, M.C., Bénarous, R., 1999. Interactions of the
cytoplasmic domains of human and simian retroviral transmembrane
proteins with components of the clathrin adaptor complexes modulate
intracellular and cell surface expression of envelope glycoproteins. J. Virol.
73, 1350–1361.
Brown, W.C., Bissey, L., Logan, K.S., Pedersen, N.C., Elder, J.H., Collisson,
E.W., 1991. Feline immunodeficiency virus infects both CD4+ and CD8+
T lymphocytes. J. Virol. 65, 3359–3364.
Brunner, D., Pedersen, N.C., 1989. Infection of peritoneal macrophages in
413C.C.P. Celma et al. / Virology 366 (2007) 405–414vitro and in vivo with feline immunodeficiency virus. J. Virol. 63,
5483–5488.
Celma, C.C.P., Manrique, J.M., Affranchino, J.L., Hunter, E., González, S.A.,
2001. Domains in the simian immunodeficiency virus gp41 cytoplasmic
tail required for envelope incorporation into particles. Virology 283,
253–261.
Chakrabarti, L., Emerman, M., Tiollais, P., Sonigo, P., 1989. The cytoplasmic
domain of simian immunodeficiency virus transmembrane protein mod-
ulates infectivity. J. Virol. 63, 4395–4403.
Dean, G.A., Himathongkham, S., Sparger, E.E., 1999. Differential cell tropism
of feline immunodeficiency virus molecular clones in vivo. J. Virol. 73,
2596–2603.
de Parseval, A., Elder, J.H., 2001. Binding of recombinant feline immunode-
ficiency virus surface glycoprotein to feline cells: role of CXCR4, cell-
surface heparans, and an unidentified non-CXCR4 receptor. J. Virol. 75,
4528–4539.
de Parseval, A., Chatterji, U., Sun, P., Elder, J.H., 2004. Feline immunodefi-
ciency virus targets activated CD4+ T cells by using CD134 as a binding
receptor. Proc. Natl. Acad. Sci. U.S.A. 101, 13044–13049.
Dow, S.W., Mathiason, C.K., Hoover, E.A., 1999. In vivo monocyte tropism of
pathogenic feline immunodeficiency viruses. J. Virol. 73, 6852–6861.
Dubay, J.W., Roberts, S.J., Hahn, B.H., Hunter, E., 1992. Truncation of the
human immunodeficiency virus type 1 transmembrane glycoprotein
cytoplasmic domain blocks virus infectivity. J. Virol. 66, 6616–6625.
Earl, P.L., Koenig, S., Moss, B., 1991. Biological and immunological properties
of human immunodeficiency virus type 1 envelope glycoprotein: analysis of
proteins with truncations and deletions expressed by recombinant vaccinia
viruses. J. Virol. 65, 31–41.
Edwards, T.G., Wyss, S., Reeves, J.D., Zolla-Pazner, S., Hoxie, J.A., Doms,
R.W., Baribaud, F., 2002. Truncation of the cytoplasmic domain induces
exposure of conserved regions in the ectodomain of human immuno-
deficiency virus type 1 envelope glycoprotein. J. Virol. 76, 2683–2691.
English, R.V., Johnson, C.M., Gebhard, D.H., Tompkins, M.B., 1993. In vivo
lymphocyte tropism of feline immunodeficiency virus. J. Virol. 67,
5175–5186.
Freed, E.O., Martin, M.A., 1995. Virion incorporation of envelope glycoproteins
with long but not short cytoplasmic tails is blocked by specific, single amino
acid substitutions in the human immunodeficiency virus type 1 matrix.
J. Virol. 69, 1984–1989.
Freed, E.O., Martin, M.A., 1996. Domains of the human immunodeficiency
virus type 1 matrix and gp41 cytoplasmic tail required for envelope
incorporation into virions. J. Virol. 70, 341–351.
Gabuzda, D., Lever, A., Terwilliger, E., Sodroski, J., 1992. Effects of deletions
in the cytoplasmic domain on biological functions of human immunode-
ficiency virus type 1 envelope glycoproteins. J. Virol. 66, 3306–3315.
Garg, H., Fuller, F.J., Tompkins, W.A.F., 2004. Mechanism of feline
immunodeficiency virus envelope glycoprotein-mediated fusion. Virology
321, 274–286.
Giannecchini, S., Bonci, F., Pistello, M., Matteucci, D., Sichi, O., Rovero, P.,
Bendinelli, M., 2004. The membrane-proximal tryptophan-rich region in the
transmembrane glycoprotein ectodomain of feline immunodeficiency virus
is important for cell entry. Virology 320, 156–166.
González, S.A., Burny, A., Affranchino, J.L., 1996. Identification of domains in
the simian immunodeficiency virus matrix protein essential for assembly
and envelope glycoprotein incorporation. J. Virol. 70, 6384–6389.
Hosie, M.J., Willett, B.J., Dunsford, T.H., Jarrett, O., Neil, J.C., 1993. A
monoclonal antibody which blocks infection with feline immunodeficiency
virus identifies a possible non-CD4 receptor. J. Virol. 67, 1667–1671.
Hosie, M.J., Klein, D., Binley, J.M., Dunsford, T.H., Jarrett, O., Neil, J.C.,
Knapp, E., Giannecchini, S., Matteucci, D., Bendinelli, M., Hoxie, J.A.,
Willett, B.J., 2005. Vaccination with an inactivated virulent feline
immunodeficiency virus engineered to express high levels of Env. J. Virol.
79, 1954–1957.
Hunter, E., 1997. gp41, a multifunctional protein involved in HIV entry and
pathogenesis. In: Korber, B., Hahn, B., Foley, B., Mellors, J.W., Leitner, T.,
Myers, G., McCutchan, F., Kuiken, C.L. (Eds.), Human Retroviruses and
AIDS 1997: A Compilation and Analysis of Nucleic Acid and Amino Acid
Sequences. Los Alamos Natl. Lab, Los Alamos, NM, pp. Iii-55–iii-73.Hunter, E., Swanstrom, R., 1990. Retrovirus envelope glycoproteins. Curr. Top.
Microbiol. Immunol. 157, 187–253.
Johnston, P.B., Dubay, J.W., Hunter, E., 1993. Truncations of the simian
immunodeficiency virus transmembrane protein confer expanded host range
by removing a block to virus entry into cells. J. Virol. 67, 3077–3086.
Kalia, V., Sarkar, S., Gupta, P., Montelaro, R.C., 2003. Rational site-directed
mutations of the LLP-1 and LLP-2 lentivirus lytic peptide domains in the
intracytoplasmic tail of human immunodeficiency virus type 1 gp41 indicate
common functions in cell–cell fusion but distinct roles in virus envelope
incorporation. J. Virol. 77, 3634–3646.
Kimpton, J., Emerman, E., 1992. Detection of replication-competent and
pseudotyped human immunodeficiency virus with a sensitive cell line on the
basis of activation of an integrated β-galactosidase gene. J. Virol. 66,
2232–2239.
Kodama, T., Wooley, D.P., Naidu, Y.M., Kestler, H.W., Daniel, M.D., Li, Y.,
Desrosiers, R.C., 1989. Significance of premature stop codons in env of
simian immunodeficiency virus. J. Virol. 63, 4709–4714.
LaBranche, C.C., Sauter, M.M., Haggarty, B.S., Vance, P.J., Romano, J., Hart, T.
K., Bugelski, P.J., Marsh, M., Hoxie, J.A., 1995. A single amino acid change
in the cytoplasmic domain of the simian immunodeficiency virus
transmembrane molecule increases envelope glycoprotein expression on
infected cells. J. Virol. 69, 5217–5227.
Mammano, F., Kondo, E., Sodroski, J., Bukovsky, A., Göttlinger, H.G., 1995.
Rescue of human immunodeficiency virus type 1 matrix protein mutants by
envelope glycoproteins with short cytoplasmic domains. J. Virol. 69,
3824–3830.
Manrique, J.M., Celma, C.C.P., Affranchino, J.L., Hunter, E., González, S.A.,
2001. Small variations in the length of the cytoplasmic domain of the simian
immunodeficiency virus transmembrane protein drastically affect envelope
incorporation and virus entry. AIDS Res. Hum. Retroviruses 17,
1615–1624.
Manrique, J.M., Celma, C.C.P., Hunter, E., Affranchino, J.L., González, S.A.,
2003. Positive and negative modulation of virus infectivity and envelope
glycoprotein incorporation into virions by amino acid substitutions at the N-
terminus of the simian immunodeficiency virus matrix protein. J. Virol. 77,
10881–10888.
Manrique, M.L., Rauddi, M.L., González, S.A., Affranchino, J.L., 2004.
Functional domains in the feline immunodeficiency virus nucleocapsid
protein. Virology 327, 83–92.
Murakami, T., Freed, E.O., 2000. Genetic evidence for an interaction between
human immunodeficiency virus type 1 matrix and α-helix 2 of the gp41
cytoplasmic tail. J. Virol. 74, 3548–3554.
Olmsted, R.A., Barnes, A.K., Yamamoto, J.K., Hirsch, V.M., Purcell, R.H.,
Johnson, P.R., 1989. Molecular cloning of feline immunodeficiency virus.
Proc. Natl. Acad. Sci. USA 86, 2448–2452.
Pancino, G., Camoin, L., Sonigo, P., 1995. Structural analysis of the principal
immunodominant domain of the feline immunodeficiency virus transmem-
brane glycoprotein. J. Virol. 69, 2110–2118.
Pedersen, N.C., Ho, E.W., Brown, M.L., Yamamoto, J.K., 1987. Isolation of a T-
lymphotropic virus from domestic cats with an immunodeficiency-like
syndrome. Science 235, 790–793.
Phillips, T.R., Lamont, C., Konings, D.A., Shacklett, B.L., Hamson, C.A.,
Luciw, P.A., Elder, J.H., 1992. Identification of the Rev transactivation and
Rev-responsive elements of feline immunodeficiency virus. J. Virol. 66,
5464–5471.
Piller, S.C., Dubay, J.W., Derdeyn, C.A., Hunter, E., 2000. Mutational analysis
of conserved domains within the cytoplasmic tail of gp41 from human
immunodeficiency virus type 1: effects on glycoprotein incorporation and
infectivity. J. Virol. 74, 11717–11723.
Poeschla, E.M., Looney, D.J., 1998. CXCR4 is required by a nonprimate
lentivirus: heterologous expression of feline immunodeficiency virus in
human, rodent, and feline cells. J. Virol. 72, 6858–6866.
Rice, N.R., Henderson, L.E., Sowder, R.C., Copeland, T.D., Oroszlan, S.,
Edwards, J.F., 1990. Synthesis and processing of the transmembrane
envelope protein of equine infectious anemia virus. J. Virol. 64, 3770–3778.
Richardson, J., Pancino, G., Merat, R., Leste-Lasserre, T., Moraillon, A.,
Schneider-Mergener, J., Alizon, M., Sonigo, P., Heveker, N., 1999.
Shared usage of the chemokine receptor CXCR4 by primary and
414 C.C.P. Celma et al. / Virology 366 (2007) 405–414laboratory-adapted strains of feline immunodeficiency virus. J. Virol. 73,
3661–3671.
Ritter Jr., G.D., Mulligan, M.J., Lydy, S.L., Compans, R.W., 1993. Cell fusion
activity of the simian immunodeficiency virus envelope protein is modulated
by the intracytoplasmic domain. Virology 197, 255–264.
Saltarelli, M., Querat, G., Konings, D.A., Vigne, R., Clements, J.E., 1990.
Nucleotide sequence and transcriptional analysis of molecular clones of
CAEV which generate infectious virus. Virology 179, 347–364.
Shimojima, M., Miyasawa, T., Ikeda, Y., McMonagle, E.L., Haining, H.,
Akashi, H., Takeuchi, Y., Hosie, M.J., Willett, B.J., 2004. Use of CD134 as a
primary receptor by the feline immunodeficiency virus. Science 303,
1192–1195.
Sonigo, P., Alizon, M., Staskus, K., Klatzmann, D., Cole, S., Danos, O.,
Retzel, E., Tiollais, P., Haase, A., Wain-Hobson, S., 1985. Nucleotide
sequence of the visna lentivirus: relationship with the AIDS virus. Cell 42,
369–382.
Spies, C.P., Compans, R.W., 1994. Effects of cytoplasmic domain length on cell
surface expression and syncytium-forming capacity of the simian immuno-
deficiency virus envelope glycoprotein. Virology 203, 8–19.
Verschoor, E.J., Hulskotte, E.G.J., Ederveen, J., Koolen, M.J.M., Horzinek,M.C., Rottier, P.J.M., 1993. Post-translational processing of the feline
immunodeficiency virus envelope precursor protein. Virology 193, 433–438.
Willett, B.J., Picard, L., Hosie, M.J., Turner, J.D., Adema, K., Clapham, P.R.,
1997. Shared usage of the chemokine receptor CXCR4 by the feline and
human immunodeficiency viruses. J. Virol. 71, 6407–6415.
Wyma, D.J., Kotov, A., Aiken, C., 2000. Evidence for a stable interaction of
gp41 with Pr55Gag in immature human immunodeficiency virus type 1
particles. J. Virol. 74, 9381–9387.
Wyss, S., Dimitrov, A.S., Baribaud, F., Edwards, T.G., Blumenthal, R., Hoxie,
J.A., 2005. Regulation of human immunodeficiency virus type 1 envelope
glycoprotein fusion by a membrane-interactive domain in the gp41
cytoplasmic tail. J. Virol. 79, 12231–12241.
Yu, X., Yuan, X., McLane, M.F., Lee, T.-H., Essex, M., 1993. Mutations in the
cytoplasmic domain of human immunodeficiency virus type 1 transmem-
brane protein impair the incorporation of Env proteins into mature virions.
J. Virol. 67, 213–221.
Zingler, K., Littman, D.R., 1993. Truncation of the cytoplasmic domain of the
simian immunodeficiency virus envelope glycoprotein increases Env
incorporation into particles and fusogenicity and infectivity. J. Virol. 67,
2824–2831.
